Can-Fite BioPharma Ltd. (CANF) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Can-Fite BioPharma Ltd.

    AMEX: CANF · Real-Time Price · USD
    0.62
    0.01 (2.33%)
    At close: Oct 03, 2025, 3:57 PM
    0.61
    -2.05%
    After-hours: Oct 03, 2025, 07:30 PM EDT

    Can-Fite BioPharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.5 -1.23 -1.64 -1.57
    PEG Ratio
    		 0.04 0.02 0.03 0.05
    PS Ratio
    		 17.54 12.62 20.58 23.13
    PB Ratio
    		 2.18 1.50 3.73 1.37
    P/FCF Ratio
    		 -1.55 -1.11 -1.54 -2
    P/OCF Ratio
    		 -1.55 -1.11 -1.54 -2
    OCF/S Ratio
    		 -11.33 -11.36 -13.33 -11.56
    Debt / Equity Ratio
    		 0.02 0.01 0.01 0.01
    Quick Ratio
    		 4.38 4.90 3.68 7.37
    Current Ratio
    		 4.38 4.90 3.66 7.35
    Asset Turnover
    		 0.07 0.07 0.09 0.04
    Interest Coverage
    		 -580.71 -585.36 -631.04 -713.44
    Return on Equity
    		 -1.45 -1.22 -2.27 -0.88
    Return on Assets
    		 -0.86 -0.76 -1.1 -0.62
    Return on Invested Capital
    		 -1.13 -1.02 -1.52 -0.73
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 1.00 1.00
    Net Profit Margin
    		 -11.69 -10.27 -12.56 -14.77
    Pretax Profit Margin
    		 -11.69 -10.27 -12.56 -14.79
    Operating Profit Margin
    		 -12.06 -11.03 -12.46 -15.06
    FCF Margin
    		 -11.34 -11.36 -13.35 -11.57
    EBITDA Margin
    		 -12.05 -11.01 -12.45 -15.04

    Add to Watchlist